Our reimbursement feasibility analysis identifies both opportunities and roadblocks before a new medical product is fully defined.

We establish a strategic reimbursement plan and conduct cost modeling early in the product development process to increase a product's chances for success in the marketplace.

Our experts can assist in designing clinical trials that will collect data to demonstrate a product's cost effectiveness versus other treatment options.

Our reimbursement analysis provides information that can assist in regulatory decisions, such as whether a company should pursue a 510K submission for a particular product or consider a pre-market approval (PMA). A PMA can help to differentiate a product and demonstrate cost savings over other options, providing stronger reimbursement data.

Our alliance partner, Horwath Resource Group, is available to support all of your FDA regulatory needs including the determination of regulatory strategies and submission services for all classes of medical devices.

Through payer advocacy activities and provider assistance programs, we can help introduce a new product to multiple audiences in targeted ways that will determine its ultimate success.

Economic modeling and analyses can be used to expand markets and enhance product sales. In addition, carefully planned, ongoing advocacy and reimbursement education can improve opportunities for long-term product success.